Compare ADMA Biologics Inc (ADMA) vs Ecolab Inc. (ECL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Ecolab Inc. — how do they compare? ADMA Biologics Inc trades at $9.06 (market cap $2.13B), while Ecolab Inc. trades at $274.1 (market cap $79.67B). The key difference: Ecolab Inc. is far larger — about 37.4× ADMA Biologics Inc's market cap, and Ecolab Inc. pays a 1.03% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | ECL | |
|---|---|---|
Market Cap | $2.13B | $79.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $308.35 |
52-Week Low | $7.60 | $245.73 |
Enterprise Value | $2.20B | $88.42B |
Dividend Yield | — | 1.03% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →
